Back to results
US 2012/0237534 A1Published application
Hyr1 as a target for active and passive immunization against candida
AssigneeLos Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
InventorsYue Fu, Guanpingsheng Luo, Ashraf Ibrahim, Brad Spellberg, John Edwards, JR.
Life of this patent
Estimating the term…
Abstract
The invention features HYR1 as a vaccine target and as a prophylactic strategy for combating disseminated candidiasis.
Claims25
A vaccine comprising a polypeptide substantially identical to a fragment of a HYR1 polypeptide.
A method of treating or preventing a candidiasis infection, said method comprising administering an effective amount of an isolated polypeptide substantially identical to a fragment of a HYR1 polypeptide.
Dependencies are inferred from the claim text.